久久婷婷国产综合精品,久久久久久久性潮,换脸国产av一区二区三区,韩国精品一区二区三区无码视频 ,久久久久成人精品无码

  • Pear Therapeutics Announces FDA Submission for Somryst americanpharmaceuticalreview
    July 19, 2019
    Pear Therapeutics announced the filing of a submission to the U.S. Food and Drug Administration (FDA) seeking marketing authorization for Somryst?, a prescription digital therapeutic (PDT) intended for use in the treatment of adults with chronic insomnia
  • PEAR Therapeutics Scores $50M in Series B Funding Round biospace
    January 03, 2018
    Digital therapy pioneer Pear Therapeutics Temasek led the $ 5.9 million in Series B financing, joined the new and existing investors 5AM Ventures

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194
+86 15021993094

PharmaSources Customer Service